Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms

1 Views
administrator
administrator
07/29/23

Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next